Assembly BiosciencesASMB
13F holders, Q1 2024 (March 31)24holders
2famous investors
$13.30avg. 13F price*
At the end of Q1 2024, 24 institutions reported holding Assembly Biosciences Inc. (ASMB) in their 13F filings. The largest holders were Vanguard Group Inc. ($2.6M), Millennium Management ($1.7M) and BlackRock Inc. ($1.0M). 2 famous investors held it, including Israel Englander (0.0% of Millennium Management's portfolio) and Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Assembly Biosciences Inc.
- CUSIP
- 045396207
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024
No earlier quarter to compare with.
Ownership 24 holders
| Vanguard Group Inc. | 0.00% | Add +0.7% | 196,368 | $2.6M |
| Millennium Management | 0.00% | Add +3.4% | 124,922 | $1.7M |
| BlackRock Inc. | 0.00% | Reduce -1.3% | 77,961 | $1.0M |
| Geode Capital Management, LLC | 0.00% | Add +2.4% | 52,197 | $694K |
| Acuitas Investments, LLC | 0.33% | Add +124.7% | 49,732 | $661K |
| Renaissance Technologies | 0.00% | Add +10.0% | 39,460 | $525K |
| Federated Hermes, Inc. | 0.00% | No change | 25,394 | $338K |
| Bridgeway Capital Management, LLC | 0.00% | No change | 14,500 | $193K |
| State Street Corp. | 0.00% | No change | 12,109 | $161K |
| FMR LLC | 0.00% | Reduce -0.4% | 11,318 | $151K |
| Northern Trust Corp. | 0.00% | Reduce -3.4% | 10,559 | $140K |
| Marquette Asset Management, LLC | 0.02% | Add +98.7% | 9,016 | $120K |
| Amundi | 0.00% | No change | 7,934 | $106K |
| Acadian Asset Management LLC | 0.00% | No change | 5,868 | $78K |
| UBS Group AG | 0.00% | Add +60.7% | 3,235 | $43K |
| Barclays PLC | 0.00% | No change | 2,994 | $40K |
| Morgan Stanley | 0.00% | Reduce -3.3% | 2,472 | $33K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -20.8% | 857 | $11K |
| Rhumbline Advisers | 0.00% | Reduce -0.6% | 199 | $3K |
| Royal Bank of Canada | 0.00% | Add +73.6% | 79 | $1K |
| EverSource Wealth Advisors, LLC | 0.00% | Reduce -0.6% | 55 | $686 |
| Wells Fargo & Company | 0.00% | Add +4.3% | 44 | $585 |
| JPMorgan Chase & Co. | 0.00% | Reduce -10.6% | 7 | $93 |
| Qube Research & Technologies Ltd | 0.00% | Reduce -16.3% | 3 | $40 |
"% of holder's portfolio" is ASMB's weight in each manager's 13F, not the share of Assembly Biosciences Inc. the manager owns.